Nephros Inc. (NASDAQ:NEPH) Sees Large Growth in Short Interest

Nephros Inc. (NASDAQ:NEPH) was the recipient of a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 9,897 shares, an increase of 32.0% from the January 15th total of 7,496 shares. Based on an average daily volume of 44,093 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.1% of the shares of the company are sold short. Approximately 0.1% of the shares of the company are sold short. Based on an average daily volume of 44,093 shares, the days-to-cover ratio is presently 0.2 days.

Institutional Trading of Nephros

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC increased its holdings in shares of Nephros by 3.2% during the second quarter. Geode Capital Management LLC now owns 93,187 shares of the company’s stock worth $381,000 after buying an additional 2,898 shares in the last quarter. Topline Capital Management LLC grew its position in Nephros by 13.1% during the 2nd quarter. Topline Capital Management LLC now owns 477,449 shares of the company’s stock worth $1,953,000 after acquiring an additional 55,360 shares during the last quarter. Dimensional Fund Advisors LP bought a new position in Nephros in the third quarter valued at about $64,000. Citadel Advisors LLC boosted its stake in shares of Nephros by 39.2% during the third quarter. Citadel Advisors LLC now owns 16,545 shares of the company’s stock valued at $78,000 after purchasing an additional 4,655 shares in the last quarter. Finally, Navellier & Associates Inc. bought a new stake in shares of Nephros during the fourth quarter worth about $133,000. Institutional investors own 41.10% of the company’s stock.

Nephros Price Performance

Nephros stock opened at $4.10 on Monday. The stock’s fifty day moving average price is $4.65 and its two-hundred day moving average price is $4.64. The firm has a market cap of $43.58 million, a PE ratio of 31.54 and a beta of 1.40. Nephros has a one year low of $1.39 and a one year high of $6.42.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Nephros in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $6.00.

About Nephros

Nephros, Inc is a development-stage company specializing in advanced water filtration and purification technologies for medical, laboratory, industrial and defense applications. The company’s core offering centers on proprietary hollow fiber ultrafilters designed to remove bacteria, viruses, endotoxins and particulates from water streams. These ultrafilters are used in hemodialysis systems to protect patient treatment, in pharmaceutical and laboratory environments to ensure water quality and in critical field-deployable units for military and emergency response.

The company’s product portfolio includes standalone filtration cartridges for point-of-use and point-of-entry installations in dialysis clinics and hospitals, as well as bench-top and portable water purification systems.